{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:55Z","timestamp":1787020495292,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dual-specificity phosphatases (DUSPs) can dephosphorylate both tyrosine and serine\/threonine residues of their substrates and regulate T cell-mediated immunity and autoimmunity. The aim of this study was to investigate the potential roles of DUSPs in ankylosing spondylitis (AS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixty AS patients and 45 healthy controls were enrolled in this study. Associations of gene expression of 23 DUSPs in peripheral T cells with inflammatory cytokine gene expression and disease activity of AS were analyzed. Finally, we investigated whether the characteristics of AS are developed in DUSP-knockout mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mRNA levels of DUSP4, DUSP5, DUSP6, DUSP7, and DUSP14 in peripheral T cells were significantly higher in AS group than those of healthy controls (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05), while DUSP22 (also named JKAP) mRNA levels were significantly lower in AS group than healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). The mRNA levels of DUSP4, DUSP5, DUSP6, DUSP7, and DUSP14 in T cells were positively correlated with mRNA levels of tumor necrosis factor-\u03b1 (TNF-\u03b1), whereas DUSP22 was inversely correlated (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05). In addition, inverse correlations of DUSP22 gene expression in peripheral T cells with C-reactive protein, erythrocyte sedimentation rate, and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were observed (all\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.05). More importantly, aged DUSP22 knockout mice spontaneously developed syndesmophyte formation, which was accompanied by an increase of TNF-\u03b1\n                      <jats:sup>+<\/jats:sup>\n                      , interleukin-17A\n                      <jats:sup>+<\/jats:sup>\n                      , and interferon-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DUSP22 may play a crucial role in the pathogenesis and regulation of disease activity of AS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-023-02745-6","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T10:04:34Z","timestamp":1676023474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dual-specificity phosphatases 22-deficient T cells contribute to the pathogenesis of ankylosing spondylitis"],"prefix":"10.1186","volume":"21","author":[{"given":"Ming-Han","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Chia","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Tei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"1","key":"2745_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2045-3701-2-24","volume":"2","author":"CY Huang","year":"2012","unstructured":"Huang CY, Tan TH. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012;2(1):24.","journal-title":"Cell Biosci."},{"issue":"11","key":"2745_CR2","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms20112668","volume":"20","author":"HF Chen","year":"2019","unstructured":"Chen HF, Chuang HC, Tan TH. Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability. Int J Mol Sci. 2019;20(11):2668.","journal-title":"Int J Mol Sci."},{"issue":"12","key":"2745_CR3","doi-asserted-by":"publisher","first-page":"14653","DOI":"10.1096\/fj.201802558RR","volume":"33","author":"HP Lin","year":"2019","unstructured":"Lin HP, Ho HM, Chang CW, Yeh SD, Su YW, Tan TH, et al. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis. FASEB J. 2019;33(12):14653\u201367.","journal-title":"FASEB J."},{"issue":"5","key":"2745_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd2289","volume":"6","author":"KL Jeffrey","year":"2007","unstructured":"Jeffrey KL, Camps M, Rommel C, Mackay CR. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discovery. 2007;6(5):391\u2013403.","journal-title":"Nat Rev Drug Discovery."},{"issue":"11","key":"2745_CR5","doi-asserted-by":"publisher","first-page":"E1433","DOI":"10.3390\/cells8111433","volume":"8","author":"HC Chuang","year":"2019","unstructured":"Chuang HC, Tan TH. MAP4K family kinases and DUSP family phosphatases in T-cell signaling and systemic lupus erythematosus. Cells. 2019;8(11):E1433.","journal-title":"Cells."},{"issue":"47","key":"2745_CR6","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1038\/onc.2017.255","volume":"36","author":"YR Chen","year":"2017","unstructured":"Chen YR, Chou HC, Yang CH, Chen HY, Liu YW, Lin TY, et al. Deficiency in VHR\/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration. Oncogene. 2017;36(47):6509\u201317.","journal-title":"Oncogene."},{"issue":"6","key":"2745_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.4049\/jimmunol.2000334","volume":"205","author":"CY Yang","year":"2020","unstructured":"Yang CY, Chuang HC, Tsai CY, Xiao YZ, Yang JY, Huang RH, et al. DUSP11 attenuates lipopolysaccharide-induced macrophage activation by targeting TAK1. J Immunol. 2020;205(6):1644\u201352.","journal-title":"J Immunol."},{"issue":"1","key":"2745_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-022-00826-x","volume":"29","author":"HC Chou","year":"2022","unstructured":"Chou HC, Cheng CM, Yang CH, Lin TY, Liu YW, Tan TH, et al. DUSP3 regulates phosphorylation-mediated degradation of occludin and is required for maintaining epithelial tight junction. J Biomed Sci. 2022;29(1):40.","journal-title":"J Biomed Sci."},{"issue":"39","key":"2745_CR9","doi-asserted-by":"publisher","first-page":"36592","DOI":"10.1074\/jbc.M200453200","volume":"277","author":"AJ Chen","year":"2002","unstructured":"Chen AJ, Zhou G, Juan T, Colicos SM, Cannon JP, Cabriera-Hansen M, et al. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway. J Biol Chem. 2002;277(39):36592\u2013601.","journal-title":"J Biol Chem."},{"issue":"8","key":"2745_CR10","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1074\/jbc.M109.060186","volume":"285","author":"JP Li","year":"2010","unstructured":"Li JP, Fu YN, Chen YR, Tan TH. JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration. J Biol Chem. 2010;285(8):5472\u20138.","journal-title":"J Biol Chem."},{"key":"2745_CR11","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1038\/ncomms4618","volume":"5","author":"JP Li","year":"2014","unstructured":"Li JP, Yang CY, Chuang HC, Lan JL, Chen DY, Chen YM, et al. The phosphatase JKAP\/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck. Nat Commun. 2014;5:3618.","journal-title":"Nat Commun."},{"issue":"36","key":"2745_CR12","doi-asserted-by":"publisher","first-page":"57593","DOI":"10.18632\/oncotarget.11419","volume":"7","author":"HC Chuang","year":"2016","unstructured":"Chuang HC, Chen YM, Hung WT, Li JP, Chen DY, Lan JL, et al. Downregulation of the phosphatase JKAP\/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget. 2016;7(36):57593\u2013605.","journal-title":"Oncotarget."},{"issue":"12","key":"2745_CR13","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/kei047","volume":"44","author":"J Zochling","year":"2005","unstructured":"Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology. 2005;44(12):1483\u201391.","journal-title":"Rheumatology."},{"issue":"9570","key":"2745_CR14","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379\u201390.","journal-title":"Lancet."},{"issue":"1","key":"2745_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/RHU.0b013e3181637a38","volume":"14","author":"MA Khan","year":"2008","unstructured":"Khan MA. HLA-B27 and its pathogenic role. J Clin Rheumatol. 2008;14(1):50\u20132.","journal-title":"J Clin Rheumatol."},{"issue":"2","key":"2745_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrrheum.2012.233","volume":"9","author":"WP Maksymowych","year":"2013","unstructured":"Maksymowych WP. Spondyloarthritis in 2012: Advances in pathogenesis through animal models and imaging. Nat Rev Rheumatol. 2013;9(2):72\u20134.","journal-title":"Nat Rev Rheumatol."},{"key":"2745_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","volume":"7","author":"W Zhu","year":"2019","unstructured":"Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019;7:22.","journal-title":"Bone Res."},{"issue":"2","key":"2745_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.arcmed.2006.09.008","volume":"38","author":"CT Chou","year":"2007","unstructured":"Chou CT, Huo AP, Chang HN, Tsai CY, Chen WS, Wang HP. Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives. Arch Med Res. 2007;38(2):190\u20135.","journal-title":"Arch Med Res."},{"issue":"7","key":"2745_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","volume":"6","author":"LS Tam","year":"2010","unstructured":"Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol. 2010;6(7):399\u2013405.","journal-title":"Nat Rev Rheumatol."},{"issue":"1","key":"2745_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13933","volume":"1442","author":"M Lata","year":"2019","unstructured":"Lata M, Hettinghouse AS, Liu CJ. Targeting tumor necrosis factor receptors in ankylosing spondylitis. Ann N Y Acad Sci. 2019;1442(1):5\u201316.","journal-title":"Ann N Y Acad Sci."},{"issue":"6","key":"2745_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10067-015-2961-7","volume":"34","author":"SK Raychaudhuri","year":"2015","unstructured":"Raychaudhuri SK, Saxena A, Raychaudhuri SP. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol. 2015;34(6):1019\u201323.","journal-title":"Clin Rheumatol."},{"issue":"18","key":"2745_CR22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJMoa012664","volume":"346","author":"JD Gorman","year":"2002","unstructured":"Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002;346(18):1349\u201356.","journal-title":"N Engl J Med."},{"issue":"1","key":"2745_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cei.12670","volume":"183","author":"H Jethwa","year":"2015","unstructured":"Jethwa H, Bowness P. The interleukin (IL)-23\/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol. 2015;183(1):30\u20136.","journal-title":"Clin Exp Immunol."},{"issue":"9906","key":"2745_CR24","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J, Sieper J, Emery P, van der Heijde D, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2013;382(9906):1705\u201313.","journal-title":"Lancet."},{"issue":"2","key":"2745_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/eji.201041295","volume":"42","author":"CY Huang","year":"2012","unstructured":"Huang CY, Lin YC, Hsiao WY, Liao FH, Huang PY, Tan TH. DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development. Eur J Immunol. 2012;42(2):476\u201388.","journal-title":"Eur J Immunol."},{"issue":"1","key":"2745_CR26","doi-asserted-by":"publisher","first-page":"e24111","DOI":"10.1002\/jcla.24111","volume":"36","author":"C Qian","year":"2022","unstructured":"Qian C, Chen J, Xu X, Liu Q, Gu M, Lu S, et al. Measurement of synovium and serum dual specificity phosphatase 22 level: Their inter-correlation and potency as biomarkers in rheumatoid arthritis. J Clin Lab Anal. 2022;36(1):e24111.","journal-title":"J Clin Lab Anal."},{"issue":"4","key":"2745_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361\u20138.","journal-title":"Arthritis Rheum."},{"issue":"12","key":"2745_CR28","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286\u201391.","journal-title":"J Rheumatol."},{"issue":"12","key":"2745_CR29","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281\u20135.","journal-title":"J Rheumatol."},{"issue":"1","key":"2745_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","volume":"35","author":"SD Jones","year":"1996","unstructured":"Jones SD, Steiner A, Garrett SL, Calin A. The bath ankylosing spondylitis patient global score (BAS-G). Br J Rheumatol. 1996;35(1):66\u201371.","journal-title":"Br J Rheumatol."},{"issue":"1","key":"2745_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.2004.020503","volume":"64","author":"MC Creemers","year":"2005","unstructured":"Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64(1):127\u20139.","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"2745_CR32","first-page":"1670","volume":"34","author":"L Mancarella","year":"2007","unstructured":"Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol. 2007;34(8):1670\u20133.","journal-title":"J Rheumatol."},{"issue":"6","key":"2745_CR33","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3390\/ijms22062851","volume":"22","author":"DS Amarasekara","year":"2021","unstructured":"Amarasekara DS, Kim S, Rho J. Regulation of osteoblast differentiation by cytokine networks. Int J Mol Sci. 2021;22(6):2851.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"2745_CR34","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.4049\/jimmunol.1300989","volume":"192","author":"CY Yang","year":"2014","unstructured":"Yang CY, Li JP, Chiu LL, Lan JL, Chen DY, Chuang HC, et al. Dual-specificity phosphatase 14 (DUSP14\/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192(4):1547\u201357.","journal-title":"J Immunol."},{"key":"2745_CR35","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1096\/fj.201800244RR","volume":"32","author":"CY Yang","year":"2018","unstructured":"Yang CY, Chiu LL, Chang CC, Chuang HC, Tan TH. Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation. FASEB J. 2018;32:6760\u201370.","journal-title":"FASEB J."},{"issue":"4","key":"2745_CR36","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.20990","volume":"52","author":"M Rudwaleit","year":"2005","unstructured":"Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005;52(4):1000\u20138.","journal-title":"Arthritis Rheum."},{"issue":"4","key":"2745_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10067-007-0727-6","volume":"27","author":"U Dincer","year":"2008","unstructured":"Dincer U, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol. 2008;27(4):457\u201362.","journal-title":"Clin Rheumatol."},{"issue":"1","key":"2745_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5606\/ArchRheumatol.2016.5562","volume":"31","author":"S Fallahi","year":"2016","unstructured":"Fallahi S, Jamshidi AR. Diagnostic delay in ankylosing spondylitis: related factors and prognostic outcomes. Arch Rheumatol. 2016;31(1):24\u201330.","journal-title":"Arch Rheumatol."},{"issue":"2","key":"2745_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"E Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003;23(2):61\u20136.","journal-title":"Rheumatol Int."},{"key":"2745_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fimmu.2019.00305","volume":"10","author":"WP Maksymowych","year":"2019","unstructured":"Maksymowych WP. Biomarkers for diagnosis of axial spondyloarthritis, disease activity, prognosis, and prediction of response to therapy. Front Immunol. 2019;10:305.","journal-title":"Front Immunol."},{"issue":"6","key":"2745_CR41","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3109\/14397595.2015.1029221","volume":"25","author":"MH Chen","year":"2015","unstructured":"Chen MH, Chen HA, Chen WS, Tsai CY, Chou CT. Upregulation of BMP-2 expression in peripheral blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitis. Mod Rheumatol. 2015;25(6):913\u20138.","journal-title":"Mod Rheumatol."},{"issue":"3","key":"2745_CR42","doi-asserted-by":"publisher","first-page":"102760","DOI":"10.1016\/j.autrev.2021.102760","volume":"20","author":"SS Groen","year":"2021","unstructured":"Groen SS, Sinkeviciute D, Bay-Jensen AC, Thudium CS, Karsdal MA, Thomsen SF, et al. Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers. Autoimmun Rev. 2021;20(3):102760.","journal-title":"Autoimmun Rev."},{"issue":"9","key":"2745_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14(9):585\u2013600.","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"2745_CR44","doi-asserted-by":"publisher","first-page":"GMR16019322","DOI":"10.4238\/gmr16019322","volume":"16","author":"JT Wen","year":"2017","unstructured":"Wen JT, Zhang DH, Fang PF, Li MH, Wang RJ, Li SH. Role of Th1\/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitis. Genet Mol Res. 2017;16(1):GMR16019322.","journal-title":"Genet Mol Res."},{"issue":"1","key":"2745_CR45","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1038\/s41467-021-26750-6","volume":"12","author":"F Shao","year":"2021","unstructured":"Shao F, Liu Q, Zhu Y, Fan Z, Chen W, Liu S, et al. Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis. Nat Commun. 2021;12(1):6540.","journal-title":"Nat Commun."},{"issue":"1","key":"2745_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41392-022-01038-3","volume":"7","author":"J Pan","year":"2022","unstructured":"Pan J, Zhou L, Zhang C, Xu Q, Sun Y. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy. Signal Transduct Target Ther. 2022;7(1):177.","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"2745_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3899\/jrheum.080871","volume":"36","author":"X Baraliakos","year":"2009","unstructured":"Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients. J Rheumatol. 2009;36(5):997\u20131002.","journal-title":"J Rheumatol."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-023-02745-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-023-02745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T06:11:17Z","timestamp":1676268677000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-023-02745-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2745"],"URL":"https:\/\/doi.org\/10.1186\/s12916-023-02745-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonisation Good Clinical Practice guidelines. This study was approved by the Institutional Review Board of Taipei Veterans General Hospital (#2015-12-016AC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}